CONTACT: DAVE PEDERSEN
Iowa City IA 52242
(319) 335-8032; fax(319) 335-8034
Release: Oct. 4, 2000
Sherman to receive award from UI department of internal medicine
IOWA CITY, Iowa -- Barry M. Sherman, M.D., a former faculty member in the
University of Iowa department of internal medicine, will receive the department's
Distinguished Achievement Award for his professional contributions in internal
Sherman will receive the award at 1 p.m. Thursday, Oct. 5 in the Medical
Alumni Auditorium at the UI Hospitals and Clinics. The presentation is part
of "Progress in Internal Medicine," an annual conference for medical
professionals held on the UI campus. Francois M. Abboud, M.D., professor and
head of the UI department of internal medicine, will present the award. Following
the presentation, Sherman will give a lecture titled, "The Promise of
New Drug Development."
Sherman served as associate director (1971-1977) and director (1977-1985)
of the UI Clinical Research Center, overseeing the clinical research activities
of UI faculty members from various departments. His own research at the UI
made significant contributions in three major areas: human female reproductive
endocrinology; pituitary function and pituitary tumors; and endocrine changes
in patients with psychiatric illnesses. While at Iowa, Sherman also served
as associate chair for academic programs in the UI department of internal
medicine, and as chair of the UI College of Medicine's compensation committee.
He played a major role in the college's efforts related to faculty compensation,
promotion and recruitment.
In 1985, Sherman left the UI to become director of clinical research at
Genetech, then a new San Francisco-based biotechnology company that became
a model for the biotech industry. He eventually became senior vice president
and chief medical officer at the company, overseeing an
11-year boom in new drug development that included human growth hormones,
human insulin and cancer treatments.
Sherman is currently executive vice president and chief medical officer
for Pain Therapeutics, a drug development firm whose goal is to create less
addictive pain relievers.
University of Iowa Health Care describes the partnership between
the UI College of Medicine and the UI Hospitals and Clinics and the patient
care, medical education and research programs and services they provide.